![(3-endo)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine](https://static.cymitquimica.com/products/3D/img/IE22671.png "Click to enlarge")
(3-endo)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine
CAS: 76272-56-5
Ref. 3D-IE22671
| 2g | To inquire | ||
| 5g | To inquire | ||
| 10g | To inquire | ||
| 25g | To inquire | ||
| 50g | To inquire |
Product Information
- b-3-Amino-9-methyl-9-azabicyclo[3.3.1]nonaneGranisetron impurity E (free base)
- Endo-3-Amine-9-Methyl-9-Azabicyclo[3,3,1]Nonane
- Endo-3-amino-9-methyl-9-azabicyclo[3,3,1]nonane
- Endo-9-Methyl-9-Azabicyclo[3,3,1] nonane-3-Amine
- 9-Methyl-9-Azabicyclo[3.3.1]Nonan-3-Amine
- 9-Methyl-9-Azabicyclo[3.3.1]Nonan-1-Amine
Granisetron is a drug that belongs to the group of serotonin receptor antagonists. It is used as an antiemetic, mainly in the prevention and treatment of nausea and vomiting caused by cancer chemotherapy and surgery. This drug has been shown to be effective in controlling nausea and vomiting, even when given after chemotherapy or surgical procedures. Granisetron hydrochloride was synthesized in 1988 by chemists at Hoffmann-La Roche. The synthesis was patented in 1990. Potential impurities are not listed on the USP or EP pharmacopeia, but these impurities have been detected during synthesis.
Chemical properties
Technical inquiry about: 3D-IE22671 (3-endo)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
